PMID: 9544917Apr 17, 1998Paper

Successful treatment of a staphylococcal endocarditis vegetation with tissue plasminogen activator

The Journal of Pediatrics
R E FlemingS B Jureidini

Abstract

A 930 gm premature infant had Staphylococcal endocarditis with a tricuspid valvular vegetation that was unresponsive to antibiotics and not amenable to resection. Infusion of tissue plasminogen activator over a 3-day period completely lysed the vegetation. The infection cleared with continued antibiotics, and the infant recovered without sequelae.

References

Apr 1, 1995·Clinical Pediatrics·A H Daher, F E Berkowitz
Jan 1, 1994·Acta Paediatrica·I K Mecrow, E J Ladusans

❮ Previous
Next ❯

Citations

Sep 5, 2007·Pediatric Cardiology·Edgard A BendalyRoger A Hurwitz
Feb 23, 2018·Scientific Reports·Kirby R LattweinKlazina Kooiman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.